OTC · CRYO
American CryoStem Corporation
$0.00-$0.04 (-99.75%)
American CryoStem Corporation: Healthcare · Biotechnology.
Loading market information…
OTC · LCAR · USD
Stock price
Quote as of Dec 13, 2022, 05:19 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Lescarden Inc. operates as a pharmaceutical company, concentrating on the investigation, refinement, and market distribution of medicinal products aimed at managing and curing various illnesses. Its global reach extends across the United States, Europe, and South Korea. The company's premier offering is Catrix Wound Dressing, a product specifically designed for the treatment of persistent lesions, burns, and difficult-to-heal wounds, such as decubitus, venous stasis, and diabetic ulcers. Beyond this, Lescarden provides a range of Catrix-derived solutions for wound and skin care, targeting the aesthetic surgery, dermatological, and medical spa sectors. Furthermore, the organization manufactures dietary supplements, including Bio-Cartilage and Poly-NAG, which is a patented glucosamine polymer. Lescarden also licenses its unique technologies to other enterprises for wider commercial application. Founded in 1960, Lescarden Inc. has its main office situated in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:08 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00-$0.04 (-99.75%)
American CryoStem Corporation: Healthcare · Biotechnology.
$0.00+$0.00 (+1,000.0%)
Allied Healthcare Products, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
ER Urgent Care Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.39% below the high.
$0.00+$0.00 (0.0%)
GeneThera, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.33% below the high.
$0.00$0.00 (0.0%)
DermTech, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.83% below the high.
$0.00$0.00 (0.0%)
Tauriga Sciences, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-99.0%)
EPIRUS Biopharmaceuticals, Inc.: Healthcare · Biotechnology.
$0.00-$0.00 (-100.0%)
MDEChem, Inc.: Healthcare · Biotechnology.
